Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)

Blood (2016) 128 (22): 758.

https://doi.org/10.1182/blood.V128.22.758.758

Published: 2016

Journal Articles

The BCL11B Tumor Suppressor Is Mutated In Human T-Cell Acute Lymphoblastic Leukemia

Alejandro Gutierrez, MD, Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Julia Etchin, PhD, Alexei Protopopov, PhD, Jianhua Zhang, PhD, Lynda Chin, MD, Lewis B. Silverman, MD, Stuart Winter, MD, Stephen Hunger, MD, Stephen E. Sallan, MD, Shan Zha, PhD, Frederick Alt, PhD, A. Thomas Look, MD

Blood (2010) 116 (21): 4177.

https://doi.org/10.1182/blood.V116.21.4177.4177

Published: 2010

Journal Articles

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

Brent Wood, MD, PhD, Stuart Winter, MD, Kimberly Dunsmore, MD, Elizabeth Raetz, MD, Michael J. Borowitz, MD, PhD, Meenakshi Devidas, PhD, Naomi J. Winick, MD, William L. Carroll, MD, Stephen P Hunger, MD, Mignon L. Loh, MD

Blood (2009) 114 (22): 9.

https://doi.org/10.1182/blood.V114.22.9.9

Published: 2009

Journal Articles

Absence of T-Cell Receptor Gene Rearrangements Predicts Induction Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Alejandro Gutierrez, M.D., Ruta Grebliunaite, Suzanne E. Dahlberg, PhD, Donna Neuberg, ScD, Jianhua Zhang, PhD, Takaomi Sanda, M.D., Ph.D., Alexei Protopopov, Lynda Chin, MD, Stuart Winter, MD, Richard S. Larson, MD, PhD, Jeffery Lorne Kutok, MD, PhD, Lewis B. Silverman, MD, Stephen P Hunger, MD, Stephen E. Sallan, MD, A. Thomas Look, MD

Blood (2009) 114 (22): 910.

https://doi.org/10.1182/blood.V114.22.910.910

Published: 2009

Journal Articles

Inactivation of the INK4A/ARF ( CDKN2 ) locus Cooperates with HMGA1 in T-Cell Leukemogenesis.

Linda Resar, MD, Francescopaolo Di Cello, Ph.D., Surajit Dhara, Ph.D., Jeanne Kowalski, Ph.D., Ossama Elbahlouh, M.D., Joelle Hillion, Ph.D., Stuart Winter, MD, Richard S. Larson, MD, PhD, David Huso, D.V.M., Ph.D.

Blood (2009) 114 (22): 3969.

https://doi.org/10.1182/blood.V114.22.3969.3969

Published: 2009

Journal Articles

LEF1 Is a Tumor Suppressor in T Cell Acute Lymphoblastic Leukemia

Alejandro Gutierrez, MD, Takaomi Sanda, MD, PhD, Stuart Winter, MD, Richard S. Larson, MD, PhD, Lewis B. Silverman, MD, Stephen P. Hunger, MD, Stephen E. Sallan, MD, A. Thomas Look, MD

Blood (2008) 112 (11): 3802.

https://doi.org/10.1182/blood.V112.11.3802.3802

Published: 2008

Journal Articles

Precursor T Cell Acute Lymphoblastic Leukemia (T-ALL) Blasts Lose Expression of Markers of Immaturity during Chemotherapy: Implications for the Detection of Minimal Residual Disease.

Mikhail Roshal, MD, PhD, Jonathan Fromm, MD, PhD, Stuart Winter, MD, Kimberly Dunsmore, MD, Brent Wood, MD, PhD

Blood (2008) 112 (11): 1521.

https://doi.org/10.1182/blood.V112.11.1521.1521

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)

The BCL11B Tumor Suppressor Is Mutated In Human T-Cell Acute Lymphoblastic Leukemia

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

Absence of T-Cell Receptor Gene Rearrangements Predicts Induction Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Inactivation of the INK4A/ARF ( CDKN2 ) locus Cooperates with HMGA1 in T-Cell Leukemogenesis.

LEF1 Is a Tumor Suppressor in T Cell Acute Lymphoblastic Leukemia

Precursor T Cell Acute Lymphoblastic Leukemia (T-ALL) Blasts Lose Expression of Markers of Immaturity during Chemotherapy: Implications for the Detection of Minimal Residual Disease.

Email alerts

ASH Publications

American Society of Hematology

Update search

Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)

The BCL11B Tumor Suppressor Is Mutated In Human T-Cell Acute Lymphoblastic Leukemia

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

Absence of T-Cell Receptor Gene Rearrangements Predicts Induction Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Inactivation of the INK4A/ARF ( CDKN2 ) locus Cooperates with HMGA1 in T-Cell Leukemogenesis.

LEF1 Is a Tumor Suppressor in T Cell Acute Lymphoblastic Leukemia

Precursor T Cell Acute Lymphoblastic Leukemia (T-ALL) Blasts Lose Expression of Markers of Immaturity during Chemotherapy: Implications for the Detection of Minimal Residual Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only